A. A. Patrikeeva

A. A. Patrikeeva

Auto-generated profile, based on publicly available information

A. A. Patrikeeva

Polyakov Samara Regional Clinical Cardiology Dispensary

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2023 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
SKS. M. Khokhlunov
S. M. Khokhlunov
GSG. V. Salamov
G. V. Salamov
ТKТ. V. Kislikhin
Т. V. Kislikhin
EKE. Yu. Kostyrin
E. Yu. Kostyrin
ATA. I. Tumanov
A. I. Tumanov
APA. A. Patrikeeva
A. A. Patrikeeva
Aim. This study aims to compare the intraoperative, immediate postoperative and long-term postoperative results of stenting followed by final kissing balloon angioplasty (FKB) and without FKB for left coronary artery (LCA) bifurcation lesions in patients with chronic ischemic heart disease.Material and methods. We plan to perform an open-label, prospective, randomized, single-center, cohort trial that will include 40 patients with left main coronary artery bifurcation lesion, who will undergo stenting procedure followed by FKB or without FKB, using the second-generation drug-eluting stents. Randomization into two groups will be done after performing coronary angiography, confirming the inclusion criteria and the absence of non-inclusion criteria and signing a written consent in 2 copies. Group 1 — stenting followed by FKB. Group 2 — stenting without FKB. The total follow-up period is 24 weeks. It is planned to contact by phone on 30th and 180th day (±7 days) of postoperative period to obtain the information about patient condition, general survival rate, the events of combined controlled points and drug therapy. During 2d phone contact, on 180th day (±7 days), a patient will be invited to undergo multispiral computed tomography of the coronary arteries.The primary combined end-point: cardiac death, nonfatal myocardial infarction, acute cerebrovascular accident and the repeat target vessel revascularization. The secondary combined end-point: thrombosis and stent restenosis.Conclusion. Our study will optimize the approach to the choice of stenting strategy (with or without FRB) for left main coronary artery bifurcation lesions in patients with chronic ischemic heart disease.

23 April 2023 in Russian Journal of Cardiology and Cardiovascular Surgery
Verified
Journal Article
Closed access
SKS.M. Khokhlunov
S.M. Khokhlunov
GSG.V. Salamov
G.V. Salamov
TKT.V. Kislukhin
T.V. Kislukhin
EKE.YU. Kostyrin
E.YU. Kostyrin
ATA.I. Tumanov
A.I. Tumanov
KNK.A. Novoselova
K.A. Novoselova
ЦЕЛЬ ИССЛЕДОВАНИЯ Сравнить ближайшие и отдаленные результаты одностентовых методик чрескожного коронарного вмешательства (ЧКВ) (линейное стентирование с финальной киссинг-пластикой (ФКП) и без нее) при бифуркационном поражении ствола левой коронарной артерии (ЛКА) у пациентов с хронической ишемической болезнью сердца (ИБС). МАТЕРИАЛ И МЕТОДЫ Анализировали данные 82 пациентов с хронической ИБС (70% мужчин), которым в период с 2017 по 2021 г. выполнено ЧКВ при бифуркационном поражении ствола ЛКА с применением стентов с лекарственным покрытием (100%). Медиана возраста пациентов составила 60 лет (95% ДИ 57,1—61,3). Пациенты ретроспективно разделены на две группы: 1-я группа — стентирование с ФКП (n=64), 2-я группа — стентирование без ФКП (n=18). Для обеспечения сопоставимости групп применяли метод псевдорандомизации. РЕЗУЛЬТАТЫ При изучении отдаленных результатов медиана периода наблюдения составила 21,5 мес (95% ДИ 19,7—27,1) в первой группе и 9 мес (95% ДИ 8—20,4) во второй группе. Статистически значимых различий в отношении риска кардиальной смерти, нефатального инфаркта миокарда, острого нарушения мозгового кровообращения, повторной реваскуляризации, рестеноза или тромбоза стента выявлено не было. В группе стентирования с ФКП зафиксировано статистически значимое увеличение медианы времени хирургического вмешательства (44 мин, 95% ДИ 43,6—55,5, p=0,048), среднего количества используемых баллонов (3,5±0,7, p=0,00001) и коронарных стентов (1,4±0,7, p=0,00019) по сравнению с группой стентирования без ФКП. Две методики показали эффективность и безопасность в лечении пациентов с хронической ИБС при «истинном» и «ложном» бифуркационном поражении ствола ЛКА. ВЫВОД Одностентовая коррекция ствола ЛКА у пациентов с хронической ИБС без сопутствующего многососудистого поражения, выраженного кальциноза стенок артерий и сахарного диабета является эффективным и безопасным методом реваскуляризации. Стентирование с ФКП и без нее показали сопоставимые результаты в ближайшем и отдаленном периоде наблюдения. Эти техники являются методами выбора хирургического лечения пациентов с хронической ИБС при различных типах бифуркационного поражения ствола ЛКА.

12 February 2024 in Russian Journal of Cardiology and Cardiovascular Surgery
Verified
Journal Article
Closed access
SKS.M. Khokhlunov
S.M. Khokhlunov
TKT.V. Kislukhin
T.V. Kislukhin
GSG.V. Salamov
G.V. Salamov
EKE.YU. Kostyrin
E.YU. Kostyrin
ATA.I. Tumanov
A.I. Tumanov
APA.A. Patrikeeva
A.A. Patrikeeva
OBJECTIVE To analyze the immediate and long-term results of single-stent and double-stent strategy for complex, true and false bifurcation lesions of the left main coronary artery (LMCA) depending on hemodynamic status of patients with acute coronary syndrome (ACS). MATERIAL AND METHODS There were 234 percutaneous coronary interventions (PCI) for bifurcation lesions of the LMCA in patients with ACS between 2017 and 2021. The median age of patients was 61.5 years (95% CI 59.2—62.3). Men prevailed (n=167, 71.4%). Patients retrospectively were divided into two groups: 183 (78.2%) patients (group 1) — single-stent strategy of bifurcation stenting, 51 (21.8%) patients (group 2) — double-stent strategy. Overall survival, immediate and long-term results up to 4 years were analyzed in subgroups depending on the type of bifurcation lesion (complex, true and false). The median follow-up period was 28 months (95% CI 25.2—28.9). Second-generation drug-eluting stents were implanted in all cases. RESULTS. T Here were more patients with ST segment elevation myocardial infarction (STEMI) in the 1st group (74 (40.4%) and 12 (23.5%), respectively, p=0.032). In the 2nd group, we observed more patients non-ST segment elevation MI (non-STEMI) (53 (29%) and 24 (47.1%) patients, respectively, p=0.018). The SYNTAX Score was higher in the 2nd group (19 (95% CI 18.4—20.3) and 24 (95% CI 22.3—25.3) points, respectively, p=0.009). Patients with false bifurcation lesion of the LMCA prevailed in the 1st group (148 (80.9%) and 7 (13.7%) patients, respectively, p<0.001). In the 2nd group, there were more patients with complex bifurcation lesions of the LMCA (13 (7.1%) and 37 (72.5%) patients, respectively). In-hospital mortality was higher in the 1st group (6 (46.1%) and 3 (8.1%) patients, respectively, p=0.006). This was due to predominant patients with Killip IV in this group (11 (84.6%) and 3 (8.1%) patients, respectively, p<0.001). Five (45%) patients with Killip IV survived in the single-stent strategy group while no similar patients were observed in the double-stent strategy group (p=0.16). Cardiac mortality was higher in the 2nd group (5 (3.5%) and 2 (28.6%) patients, respectively, p=0.035). There were no significant between-group differences in overall survival regardless of bifurcation lesion type. Cumulative risk of cardiac death, non-fatal MI, acute cerebrovascular accident, repeated revascularization, stent restenosis and thrombosis was similar in subgroups of true and false bifurcation lesions. CONCLUSION. S Ingle-stent strategy is effective in patients with ACS and true / false bifurcation lesions of the LMCA, as well as in hemodynamically unstable patients with Killip IV regardless of lesion type. Two-stent strategy may be considered for complex bifurcation lesions of the LMCA in hemodynamically stable patients with ACS.